Golden Throat Holdings Group Company Limited (HKG:6896)

Market Cap	2.76B -8.4%
Revenue (ttm)	1.05B -20.4%
Net Income	279.54M -21.2%
EPS	0.38 -21.2%
Shares Out	739.30M
PE Ratio	9.86
Forward PE	n/a
Dividend	0.34 (9.50%)
Ex-Dividend Date	Jun 16, 2025

Volume	879,000
Average Volume	677,400
Open	3.630
Previous Close	3.580
Day's Range	3.550 - 3.750
52-Week Range	3.000 - 5.650
Beta	-0.10
RSI	62.89
Earnings Date	Mar 27, 2026

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1956
• Employees: 842
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6896

Financial Performance

In 2025, HKG:6896's revenue was 943.26 million, a decrease of -20.40% compared to the previous year's 1.19 billion. Earnings were 251.20 million, a decrease of -21.16%.

Financial numbers in CNY